We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates. Our broad portfolio contains thousands of high-quality molecules that cover multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
Every year, we are increasing our sales, and delivering doses covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology, and respiratory among others.

The first among Indian pharmaceutical companies to realize and embrace the importance of investing in research, we invest up to 7-8% of our global revenues into Research and Development (R&D) every year. Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development. Our capabilities extend beyond the development of differentiated products, including liposomal products, inhalers, lyophilized injections, nasal sprays, and controlled release dosage forms.